| Group 1 | Group 2 | ||||
---|---|---|---|---|---|---|
WT | HBx Tg | P-value | WT | HBx Tg | P-value | |
Micro-fatty change | 0/39(0%) | 3/45(6.7%) | 0.101 | 9/47(19.1%) | 40/51(78.4%) | 0.000 |
Macro-fatty change | 0/39(0%) | 0/45(0%) | – | 2/47(4.3%) | 25/51(49.0%) | 0.045 |
Inflammation | 0/39(0%) | 10/45(22.2%) | 0.002 | 9/47(19.1%) | 5/51(9.8%) | 0.187 |
Necrosis | 0/39(0%) | 1/45(2.2%) | 0.349 | 0/47(0%) | 4/51(7.8%) | 0.050 |
Dysplasia | 0/39(0%) | 43/45(95.6%) | 0.000 | 0/47(0%) | 48/51(94.1%) | 0.000 |
Dysplastic nodule | 0/39(0%) | 0/45(0%) | – | 0/47(0%) | 1/51(2.0%) | 0.335 |
Tumor | 0/39(0%) | 0/45(0%) | – | 0/47(0%) | 0/51(0%) | – |
 | Group 3 | Group 4 | ||||
Micro-fatty change | 4/13(30.8%) | 15/15(100%) | 0.000 | 1/3(33.3%) | 7/8(87.5%) | 0.072 |
Macro-fatty change | 0/13(0%) | 15/15(100%) | 0.000 | 0/3(0%) | 3/8(37.5%) | 0.214 |
Inflammation | 1/13(7.7%) | 3/15(20.0%) | 0.353 | 1/3(33.3%) | 4/8(50%) | 0.621 |
Necrosis | 1/13(7.7%) | 1/15(6.7%) | 0.916 | 0/3(0%) | 2/8(25.0%) | 0.338 |
Dysplasia | 0/13(0%) | 15/15(100%) | 0.000 | 0/3(0%) | 8/8(100%) | 0.001 |
Dysplastic nodule | 0/13(0%) | 1/15(6.7%) | 0.343 | 0/3(0%) | 5/8(62.5%) | 0.064 |
Tumor | 0/13(0%) | 1/15(6.7%) | 0.343 | 0/3(0%) | 5/8(62.5%) | 0.064 |